India Approves First Dengue Vaccine QDENGA Following Regulatory Clearance
India has approved its first dengue vaccine, QDENGA, after receiving clearance from the Drug Controller General of India (DCGI). Dengue is a mosquito-borne viral disease present in over 125 countries, with India bearing nearly one-third of the global disease burden. Factors such as rapid urbanisation, climate change, and widespread mosquito breeding continue to drive infection risks across the country. QDENGA is administered as two 0.5 ml injections given under the skin, spaced three months apart.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in